Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary adrenal lymphoma.

Andrew P Grigg1, Joseph M Connors

  • 1Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Parkville, Victoria, Australia. andrew.grigg@mh.org.au

Clinical Lymphoma
|January 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Valganciclovir for CMV Prophylaxis After PTCy-Based Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy·2026
Same author

The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia.

British journal of haematology·2025
Same author

Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study.

Blood·2024
Same author

Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.

Leukemia & lymphoma·2023
Same author

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1.

Haematologica·2023
Same author

Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada.

Leukemia & lymphoma·2023
Same journal

Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.

Clinical lymphoma·2005
Same journal

A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.

Clinical lymphoma·2005
Same journal

Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.

Clinical lymphoma·2005
Same journal

ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?

Clinical lymphoma·2005
Same journal

Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Clinical lymphoma·2005
Same journal

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Clinical lymphoma·2005
See all related articles

Primary adrenal lymphoma is a rare cancer. This condition often affects older men, presenting with bilateral adrenal involvement and diffuse large B-cell histology, with limited long-term survival data.

Area of Science:

  • Oncology
  • Hematology
  • Endocrinology

Background:

  • Primary adrenal lymphoma is an uncommon extranodal lymphoma.
  • It frequently involves both adrenal glands and is predominantly diffuse large B-cell type.
  • Patients often present with systemic symptoms and adrenal insufficiency.

Purpose of the Study:

  • To review the clinical features, diagnosis, and treatment of primary adrenal lymphoma.
  • To highlight the rarity and diagnostic challenges of this condition.
  • To identify unresolved therapeutic questions and the need for further research.

Main Methods:

  • Retrospective analysis of clinical data from patients with primary adrenal lymphoma.
  • Review of existing literature on primary adrenal lymphoma.

Related Experiment Videos

  • Identification of characteristic clinical and histological features.

    • Main Results:

    • High incidence of bilateral adrenal involvement and diffuse large B-cell histology.
    • Common presentation in older men with fever, lumbar pain, and adrenal insufficiency symptoms.
    • Limited disease-free survival, possibly due to publication bias or adverse prognostic factors.

    Conclusions:

    • Primary adrenal lymphoma is a rare entity with distinct clinical characteristics.
    • Optimal treatment strategies remain unclear, including chemotherapy regimens, surgery, radiation, and CNS prophylaxis.
    • Multicenter collaborative studies are essential for advancing understanding and treatment of this rare lymphoma.